Taylor Morrison Home
TMHC
Meritage Homes
MTH
D.R. Horton
DHI
Lennar Corp
LEN
Toll Brothers
TOL
US Stock MarketDetailed Quotes
TELO Telomir Pharmaceuticals
- 4.150
- -0.090-2.12%
Close Feb 25 16:00 ET
123.52MMarket Cap-7.48P/E (TTM)
4.350High3.920Low121.26KVolume4.250Open4.240Pre Close501.20KTurnover0.69%Turnover RatioLossP/E (Static)29.76MShares9.39052wk High188.64P/B72.48MFloat Cap3.11052wk Low--Dividend TTM17.46MShs Float20.720Historical High--Div YieldTTM10.14%Amplitude3.110Historical Low4.133Avg Price1Lot Size
Telomir Pharmaceuticals News
Express News | Telomir Pharmaceuticals Inc - Telomir-1 Reverses Calcium Dysregulation in Multiple Human Cell Lines
Rodman & Renshaw Initiates Telomir Pharmaceuticals(TELO.US) With Buy Rating, Announces Target Price $15
Telomir Pharmaceuticals Initiated With a Buy at Rodman & Renshaw
Express News | Telomir Pharmaceuticals Achieves Breakthrough In Silver Ion Stabilization, Says Unlocking A New Multi-Billion Dollar Medical Market
Telomir Pharmaceuticals Seeks To Tap Multi-Billion-Dollar Market With Breakthrough In Silver Ion Stabilization For Antibacterial Treatment, Tissue Regeneration
Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)
Express News | Telomir Pharmaceuticals Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing
Telomir Pharmaceuticals | 10-K: FY2024 Annual Report
Telomir Pharmaceuticals Announces Results From Preclinical Studies of Telomir-1
Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses
Express News | Telomir Pharmaceuticals Inc - Telomir-1 Reverses Copper-Induced Ros Elevation in Human Cell Lines
Express News | Telomir Pharmaceuticals Inc - Announces Breakthrough Results With Telomir-1
Telomir Touts Potential of Telomir-1 in Addressing Oxidative Stress
Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) Biggest Owners Are Retail Investors Who Got Richer After Stock Soared 13% Last Week
Renovaro Names Nathen Fuentes as CFO
Telomir Pharmaceuticals Shares Are Trading Higher After the Company Announced Potentially Groundbreaking Findings From a Preclinical Progeria Lifespan Study.
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
Express News | Telomir Pharmaceuticals: Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria
Express News | Telomir Pharmaceuticals Inc - to Submit Ind & Inad Application by Q4 2025, With Clinical Trials Planned for 2026
EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.